Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Clinical oncology faces challenges with ineffective treatments, poor patient management, and suboptimal cancer detection.
• Current limitations include inadequate treatment efficacy, systemic toxicities, and difficulties in disease monitoring.
• There is a critical need for innovative, multifaceted solutions for targeted cancer therapies and diagnostics.

Purpose of the Study:

• To explore the potential of mesenchymal stem cells (MSCs) as carriers for targeted cancer therapy and diagnostics.
• To investigate the use of MSCs in delivering gene therapy and carrying nanoparticles for cell tracking and cancer detection.
• To discuss the synergistic application of MSCs, gene therapy, and superparamagnetic iron-oxide nanoparticles (SPIONs) for improved cancer treatment and monitoring.

Main Methods:

• Utilizing the natural tumor-homing ability and hypoimmunogenicity of MSCs.
• Employing MSCs as "Trojan Horses" for direct tumor gene therapy delivery.
• Incorporating nanoparticles, such as SPIONs, within MSCs for cell tracking and imaging via magnetic resonance imaging (MRI).

Main Results:

• MSC carriers can potentially overcome issues of vector/transgene immunogenicity and nanoparticle clearance/toxicity.
• Nanotechnology integrated with MSCs allows for cellular tracking using multimodal imaging.
• SPIONs offer a promising approach for tracking therapeutic MSCs and enhancing MRI sensitivity for cancer detection.

Conclusions:

• Synergistic approaches combining MSC carriers, gene therapy, and SPIONs hold significant promise for advancing cancer diagnostics and therapeutics.
• This multifaceted strategy addresses key challenges in current cancer treatment, including targeting, toxicity, and monitoring.
• Further development in this area could lead to more effective and safer cancer management strategies.